Redwood AI Storms Into Post-Quantum Security While Locking Down Canadian Research Funding

Redwood AI signs letter of intent to acquire Quantum.IQ in a stock swap, while a subsidiary secures CAD 240K NRC grant for quantum chemical safety analysis.

Redwood AI has kicked off a busy late spring with two big moves that signal a rapid expansion beyond its roots in artificial intelligence for drug discovery. On 28 May 2026, the company signed a non-binding letter of intent to acquire Quantum.IQ, a Vancouver-based cybersecurity firm focused on post-quantum cryptography. At the same time, a Redwood subsidiary has secured up to CAD 240,000 in backing from the National Research Council of Canada for the Q-SAFE project, which aims to develop quantum-optimised methods for classifying hazardous chemicals.

The planned Quantum.IQ takeover is structured as a pure stock swap. Redwood will issue up to 14 million of its own common shares to the Quantum.IQ shareholders — half at closing and the other half tied to specific performance milestones. All issued shares will be subject to a staggered lock-up period that runs 24 months from the date of issue, a mechanism designed to keep Quantum.IQ’s leadership team anchored to the business over the long haul.

Quantum.IQ builds software that helps organisations map out their existing encryption systems and transition to quantum-resistant standards. The platform covers everything from inventory and assessment to continuous monitoring. Its target customer base includes government agencies, defence ministries, financial institutions and critical infrastructure operators — precisely the clients that are waking up to the threat posed by future quantum computers capable of cracking today’s classical encryption.

The company is led by CEO Kevin O'Neill, who brings more than 35 years of experience in technology investing and company building. He previously co-founded Teleo Communications (later sold to Microsoft), Workfire Technologies (acquired by Packeteer) and Xtract AI Technologies (acquired by Patriot One). O'Neill is joined by CTO Dr. Elliot Holtham and Paul Dadwal, founder of Ari & Co. Capital, as part of the management team.

While the acquisition is still provisional, Redwood has been making strides on other fronts as well. Earlier in May, it entered into a collaboration with Resilience Biosciences, a clinical-stage biopharma firm also based in Vancouver, providing its AI platform for more efficient drug discovery. Separately, the NRC grant for Q-SAFE underscores a parallel push into quantum-enhanced methods for chemical safety analysis.

The LOI remains non-binding. Both parties still need to complete full due diligence, negotiate a definitive purchase agreement and secure the formal approval of the Canadian Securities Exchange. Until those conditions are met, the deal could yet fall through — and even the milestone triggers for the second tranche of shares will only become clear once the final contract is hammered out.

For now, Redwood is building on multiple fronts, using artificial intelligence as the common thread that runs from molecular simulation to cryptography analysis. The post-quantum security market is expected to expand sharply as quantum computing threats grow more tangible, and the company is betting that its technology portfolio can stretch far enough to compete in that space. Whether the operational bandwidth holds up across chemistry, biopharma and cybersecurity will be the question that investors will be watching closely.